During the past decade, University Hospital of Ferrara conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Hospital of Ferrara" #1 sponsor was "University Hospital of Ferrara" with 6 trials, followed by "Italian Society of Invasive Cardiology" with 1 trials sponsored, "Lawson Health Research Institute" with 1 trials sponsored, "Marco Valgimigli" with 1 trials sponsored and "S. Anna Hospital" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Hospital of Ferrara" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Canadian Critical Care Trials Group" with 1 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator, "European Respiratory Society" with 1 trials as a collaborator and "Eustrategy" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "University Hospital of Ferrara" are "Acute Coronary Syndrome" (1 trials), "Acute Respiratory Failure" (1 trials), "Cardiovascular Diseases" (1 trials), "Chronic Kidney Disease Stage 5 on Dialysis" (1 trials) and "Chronic Obstructive Pulmonary Disease Exacerbation" (1 trials). Many other conditions were trialed in "University Hospital of Ferrara" in a lesser frequency.

Most popular intervention types in "University Hospital of Ferrara" are "Other" (5 trials), "Behavioral" (1 trials), "Device" (1 trials), "Drug" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "177Lu-DOTATOC + 90Y-DOTATOC" (1 trials), "BFR-Walking" (1 trials), "Bare metal stent implantation" (1 trials), "Conventional therapy" (1 trials) and "Customized choice for the oral P2Y12 receptor blocker" (1 trials). Other intervention names were less common.

The vast majority of trials in "University Hospital of Ferrara" are 11 trials for "All" genders.

Currently, there are NaN active trials in "University Hospital of Ferrara". 1 are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in University Hospital of Ferrara, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University Hospital of Ferrara, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 7 trials that are defined as “Not Applicable".